Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Open-label, Parallel, Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients Having Intermittent Claudication Among Chronic Artery Occlusive Disease
Conditions
Interventions
Sarpogrelate SR
Sarpogrelate
Locations
7
South Korea
GangNeung Asan Hospital
Gangneung-si, Gangwon-do, South Korea
Inje University Ilsan Paik Hospital
Goyang-si, Gyeonggi-do, South Korea
Dong-A University Hospital
Busan, South Korea
Korea University ANAM Hospital
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
The Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, South Korea
Start Date
November 18, 2020
Primary Completion Date
March 9, 2023
Completion Date
March 9, 2023
Last Updated
September 21, 2023
NCT05132439
NCT06535568
NCT06410521
NCT05457738
NCT02593994
NCT02924857
Lead Sponsor
Yuhan Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions